Right Bundle Branch Pacing: Criteria, Characteristics, and Outcomes

Authors, Journal, Affiliations, Type, DOI

Overview

The right bundle branch is an accessible right-sided pacing target, but it had never been formally described: no criteria, no prevalence, no outcomes. This paper supplies all three. Using the conduction-system potential-to-QRS interval at the implant site, it separates HBP (potential–QRS 35–55 ms) from RBBP (<35 ms), then tests six candidate criteria against that split. The best — stimulus-to-V6RWPT longer than potential-to-V6RWPT by ≥10 ms — reflects the fact that during RBBP the wavefront must travel retrogradely up the RBB, across to the LBB, then anterogradely down it, whereas during HBP the paced and native routes are identical. By this standard, RBBP occurred in 19.6% of patients in whom HBP was intended (64/326) — 90.6% of those with a potential–QRS <35 ms and 5.6% of the rest. RBBP gave longer QRS by 10.5 ms, longer V6RWPT by 11.6 ms, and better sensing by 2.6 mV than HBP, with no difference in capture threshold, echocardiographic outcomes or 3-year mortality. Its clinical niche is narrow but real: RBBP cannot correct LBBB, yet it avoids transseptal access and offers excellent sensing and myocardial backup.

Keywords

Right bundle branch pacing; His bundle pacing; Conduction system pacing; Capture criteria; ECG

Key Takeaways

Population and definitions

The six candidate criteria

# Criterion Performance
1 Double QRS transition during threshold testing (three excitable structures: HB, RBB, septal myocardium) Present in all potential–QRS categories but much more common with shorter intervals (22.6–50% at <35 ms vs 3.5–8.2% at ≥35 ms); not specific
2 Selective paced QRS differs from native conducted QRS SN 64.1%, SP 91.1%; met in 25/39 (64.1%) of s-RBBP — all without baseline RBBB — vs 17/191 (8.9%) of s-HBP
3 Stimulus–V6RWPT > potential–V6RWPT (Δ ≥10 ms) Adopted as the diagnostic standard; 100% sensitivity when HBP and RBBP coexisted, and never met in definite HBP (100% specificity); RBBP 98.2 ± 8.8 vs 80.3 ± 8.4 ms (Δ 17.8 ms), HBP 92.6 ± 10.7 vs 92.1 ± 10.5 ms (Δ 0.5 ms, P = .07)
4 Stimulus–sQRS > potential–QRS (Δ latency ≥10 ms) RBBP 52.1 ± 8.8 vs 34.1 ± 6.5 ms (P < .0001); s-HBP difference only 4.1 ms; met in 34/39 (87.2%); AUC 0.944, SN 87.2%, SP 95.3%
5 Small V6RWPT increase (<20 ms) with loss of HB/RBB capture ns-RBBP → RVSP +21.4 ms (97.7 → 119.2) vs ns-HBP → RVSP +34.7 ms (93.6 → 128.4); AUC 0.888, SN 70.5%, SP 94.8%
6 Equal capture thresholds of conduction system and myocardium 31.2% (20/64) RBBP vs 4.2% (11/262) HBP (P < .001); SN 31.3%, SP 95.8%

Conduction and ECG characteristics

Outcomes — RBBP versus HBP (working-output captures)

Outcome RBBP (n=42) HBP (n=284) P
Acute capture threshold 1.3 (0.8–1.9) V 1.1 (0.7–1.6) V .24
Acute ventricular sensing 5.6 (3.6–8) mV 3.2 (2.3–5) mV < .001
Chronic ventricular sensing 5.6 (4–12.5) mV 3.2 (2–5.6) mV < .001
Chronic capture threshold 0.8 (0.5–1.3) V 0.8 (0.5–1.4) V .37
Threshold rise to >3 V 0 (0%) 16 (5.6%) .12
Non-reprogrammable undersensing 0 (0%) 4 (1.4%) .44
Lead revision 0 (0%) 11 (3.9%) .2
Stimulus–V6RWPT 96.4 ± 8.5 ms 92.6 ± 11 ms .01
Global paced ns-QRS 143.4 ± 10 ms 144.2 ± 16.6 ms .66
Fluoroscopy 5.5 (3.4–7.6) min 6 (3.9–11.4) min .09
Baseline LVEF → follow-up 51 ± 13.3 → 52 ± 10.4% 51.5 ± 12.6 → 53 ± 12.1% .65
ΔLVEF 2 (−25 to 10)% 1 (−23 to 6)% .41
ΔLVEDD −3 (−28 to 1) mm −1 (−24 to 2) mm .12
All-cause mortality at 3 years 12 (28.6%) 66 (23.2%) .28

Where RBBP fits

Limitations of the document

Authors' own stated limitations

Additional limitations evident in the study

Key Concepts Mentioned

Key Entities Mentioned

Wiki Pages Updated